Deo Pharmaceuticals Private Limited

Deo Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U24231TN2004PTC054831 Incorporated 06 December 2004 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹1.09 Cr
▲ 53% YoY
Net loss · FY 2024
₹17.13 Lakh
Net margin -15.7%
EBITDA · FY 2024
-₹11.94 Lakh
EBITDA margin -10.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.43 Lakh
Issued & subscribed
Open charges
₹1.17 Cr
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
3
As per MCA filings

About Deo Pharmaceuticals Private Limited

Data last updated:

Deo Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 December 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2004PTC054831. Its GSTIN is 33AACCD1212E1ZK (Tamil Nadu).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.43 Lakh. It is led by directors including Somasekharan Suresh Babu and Ramalingaiyar Sadhanantham.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.60/61 Krishna Industrial Estate Vanagaram Mettukuppam, Chennai, Tamil Nadu, India – 600095.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.09 Cr, a growth of 53% compared to the previous year. For the same year it recorded a net loss of ₹17.13 Lakh (net margin -15.7%) and EBITDA of -₹11.94 Lakh (EBITDA margin -10.9%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 2% over five years.

As per MCA filings, the company has open charges of ₹1.17 Cr on record. Court records list 22 cases involving the company, including 21 filed by the company and 1 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231TN2004PTC054831
Registration Number 054831
Incorporation Date 06 December 2004
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Deo Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.

  • Email
  • Registered Address
    No.60/61 Krishna Industrial Estate Vanagaram Mettukuppam, Chennai, Tamil Nadu, India – 600095
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Deo Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Deo Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Deo Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Deo Pharmaceuticals Private Limited, buy the company report.

Financials of Deo Pharmaceuticals Private Limited

FY 2025 filings available

Deo Pharmaceuticals Private Limited reported revenue of ₹1.09 Cr (up 53% YoY) for FY 2024.

Revenue · FY 2024
₹1.09 Cr ▲ 53%
Net loss · FY 2024
₹17.13 Lakh margin -15.7%
EBITDA · FY 2024
-₹11.94 Lakh margin -10.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 53%
3 years · compounded
▼ 42%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▼ 27%
5 years · compounded
▼ 31%

Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 53% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹11.94 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹17.13 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-10.9%
Net Profit Margin-15.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Deo Pharmaceuticals Private Limited, buy the company report.

Board of directors of Deo Pharmaceuticals Private Limited

Deo Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Somasekharan Suresh BabuDirector06 Dec 200421 Years 10 MonthsCurrent
Ramalingaiyar SadhananthamDirector12 Jan 200719 Years 9 MonthsCurrent
JayanthiAlternate Director06 May 20251 Years 5 MonthsCurrent

Auditor

Deo Pharmaceuticals Private Limited is audited by D.V.BADARINARAYANA & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
D.V.BADARINARAYANA & COFY 2023011260S

Shareholding

The shareholding of Deo Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Deo Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.17 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of Travancore₹0.68 Cr
State Bank of India₹0.49 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
21 Nov 2019100306349State Bank of India₹49 LakhOpen
23 Mar 201010214694State Bank of Travancore₹7.2 LakhOpen
08 Aug 200710068111State Bank of Travancore₹6.1 LakhOpen
02 Jun 200710073752State Bank of Travancore₹47 LakhOpen
26 May 200710073751State Bank of Travancore₹7.5 LakhOpen

To see the full charge records of Deo Pharmaceuticals Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Deo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Deo Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AACCD1212E1ZKTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Deo Pharmaceuticals Private Limited, buy the company report.

Recent activity

Deo Pharmaceuticals Private Limited has 5 board changes on record since 2004: 4 appointments and 1 cessation. The latest: Jayanthi was appointed as Alternate Director on 06 May 2025.

AGM
Deo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Jayanthi was appointed as Alternate Director.
Filing
Deo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Perumal Pillai Somasekharan ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 49.00 Lakh with Charge ID 100306349 was registered on 21 Nov 2019.
Charges
A charge with State Bank Of Travancore of Rs. 47.00 Lakh registered on 02 Jun 2007 with Charge ID 10073752 was modified on 23 Mar 2015.
Charges
A charge with State Bank Of Travancore amounted to Rs. 7.20 Lakh with Charge ID 10214694 was registered on 23 Mar 2010.
Charges
A charge with State Bank Of Travancore amounted to Rs. 6.10 Lakh with Charge ID 10068111 was registered on 08 Aug 2007.
Charges
A charge with State Bank Of Travancore amounted to Rs. 47.00 Lakh with Charge ID 10073752 was registered on 02 Jun 2007.
Charges
A charge with State Bank Of Travancore amounted to Rs. 7.50 Lakh with Charge ID 10073751 was registered on 26 May 2007.
Appointed
Ramalingaiyar Sadhanantham was appointed as Director.
Appointed
Perumal Pillai Somasekharan was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Deo Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 December 2004 (22+ years old) and is registered under CIN U24231TN2004PTC054831.

Deo Pharmaceuticals has 3 current directors:

The latest financial statements of Deo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Deo Pharmaceuticals is 33AACCD1212E1ZK, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Deo Pharmaceuticals is U24231TN2004PTC054831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Deo Pharmaceuticals has 22 court cases on record: 21 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.

Deo Pharmaceuticals was incorporated on 06 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Chennai.

Jayanthi was appointed as Alternate Director on 06 May 2025. Perumal Pillai Somasekharan ceased to be Director on 31 Mar 2020. Ramalingaiyar Sadhanantham was appointed as Director on 12 Jan 2007. Deo Pharmaceuticals has 5 board changes on record in total.

The registered office of Deo Pharmaceuticals is at No.6061 Krishna Industrial Estate Vanagaram Mettukuppam, Chennai, Tamil Nadu, India – 600095.

Deo Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.